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Abstract
A decrease in fertility can have a negative economic impact, both locally and over a broader geographical scope, and this is
especially the case with regard to the cattle industry. Therefore, much interest exists in evaluating proteins that might be
able to increase the fertility of sperm. Heparin binding proteins (HBPs), specifically the fertility associated antigen (FAA) and
the Type-2 tissue inhibitor of metalloproteinase (TIMP-2), act to favor the capacitation and acrosome reaction and perhaps
even modulate the immune system’s response toward the sperm. The objective of this research was to determine the effect
on fertility of adding recombinant FAA (rFAA) and recombinant TIMP-2 (rTIMP-2) to bovine semen before cryopreservation
for use in an artificial insemination (AI) program in a tropical environment. For this experiment, 100 crossbred (Bos taurus x
Bos indicus) heifers were selected based on their estrus cycle, body condition score (BCS), of 4 to 6 on a scale of 1 to 9, and
adequate anatomical conformation evaluated by pelvic and genital (normal) measurements. Heifers were synchronized
using estradiol benzoate (EB), CelosilH (PGF2a) (Shering-Plough) and a controlled internal drug release (CIDR) device was
inserted that contained progesterone. Inseminations were performed in two groups at random, 50 animals per group. The
control group was inseminated with conventional semen. The treatment group was inseminated with semen containing
rFAA (25 mg/mL) and rTIMP-2 (25 mg/mL). In the control group a 16% pregnancy rate was obtained versus a 40% pregnancy
rate for the HBP treatment group, resulting in a significant difference (P = 0.0037). Given the results herein, one may
conclude that the HBPs can increase fertility and could be an option for cattle in tropical conditions; however, one needs to
consider the environment, nutrition, and the genetic interaction affecting the final result in whatever reproductive program
that is implemented.
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Introduction
When the fertility decreases in males, it can present a negative
economic impact on, among other things, the production of milk
and meat from cattle [1]. The assisted reproduction technique
(ART) of artificial insemination (AI) has played a central role in
the genetic improvement of livestock. The general use of this
technique, AI, and the success of its overall potential requires the
preservation of semen for long periods of time. Even though
cryopreservation helps with the prolonged storage of semen, the
process of cryopreservation and thawing may cause irreversible
damage to sperm [2]. Evidence suggests that the seminal plasma,
which is a mixture of secretions originating in the testicles,
epididymides, and accessory glands, contains molecules that affect
the ability of the sperm to fertilize the oocyte [3]. These studies are
based on the comparison of the seminal plasma composition of
males with different levels of fertility, or by the identification of
factors of the seminal plasma that facilitate or inhibit the sperm
capacitation, fertilization, or related events [4].
Currently, many diverse proteins are being tested that may
increase the fertilization capability of sperm, being that they act
upon some process previous to pregnancy, and this is the case with
PLOS ONE | www.plosone.org 1 June 2013 | Volume 8 | Issue 6 | e65083
the heparin binding proteins (HBPs), specifically the fertility
associated antigen (FAA) and the Type-2 tissue inhibitor of
metalloproteinase (TIMP-2). According to the scientific literature,
HBPs have been viewed as actually favoring capacitation,
acrosome reaction, and altering the immune system response
toward the sperm.
Heparin Binding Proteins
Heparin is chemically similar to the glycosaminoglycans (GAGs)
that are secreted in the reproductive tract of the female. The
heparin and the GAGs of the female reproductive tract bind to
proteins on the surface of bovine sperm and this binding induces
capacitation [5]. Evidence indicates that bulls exhibiting higher
fertility produce ejaculates with more heparin binding protein on
spermatozoal membranes, i.e., sperm with a higher binding
affinity of heparin [6], compared to bulls with lower fertility [7]. It
has also been reported that the sperm of bulls with a higher fertility
have a larger frequency of acrosomal reaction in response to
compounds similar to heparin and have a higher binding affinity
by the heparin than those sperm from lower fertility bulls [8]. The
binding of heparin by sperm has been documented in rabbits,
monkeys, pigs, goats and humans [5].
The HBPs are produced by the accessory glands of the male
and secreted within the seminal fluid. The accessory glands of the
male rat (seminal vesicles, prostate, and Cowper’s gland) produce
HBPs under the control of androgens [9]. The HBPs bind to the
epididymal sperm and increase the ability of the acrosome
reaction in response to the heparin and to the proteins of the
zona pellucida [10].
The HBPs combine to form complexes with 5 levels of binding
affinity for heparin. The complex with the greatest affinity for
heparin, i.e., HBP-B5 is composed of multiple proteins (31, 24 and
14–18 kDa) [5]. Within the aforementioned group, one finds the
31 kDa HBP called FAA and the 24 kDa HBP identified as
TIMP-2 [1], [11]. The presence of FAA (identified as a DNase-1)
has been shown to be an indicator of superior fertility of bulls
based on artificial insemination field fertility trials [7]. FAA has
been identified in seminal vesicles and prostate, but has been
detected very few times in bulbourethral glands [11].
The recombinant protein FAA has DNase-1 activity, and this
can act on the neutrophil extracellular traps (NETs) in a similar
manner to that of the natural protein in the seminal plasma [12].
Alghamdi et al. [13] found that the seminal plasma contained a
protein factor or factors that can reduce the binding of neutrophils
to the sperm in vitro in a dose dependent response. Based on what
Alghamdi and Foster [12] have demonstrated, the activity of the
DNase (FAA) present in the seminal plasma digests the exposed
DNA and frees the trapped sperm, possibly resulting in more
sperm reaching the oviduct and as such increasing fertility.
With respect to TIMP-2, it has been found in seminal vesicles,
prostate, and bulboeurtheral glands. TIMP-2 acts to inhibit the
enzymatic activity of the metalloproteases (MMPs), of which are
included the interstitial collagens, gelatinases, estromelisines and
membrane MMPs. Moreover, it has been found that TIMP-2
binds to the posterior region of the acrosome [14] [15].
Preliminary studies with the recombinant proteins indicate that
in some cases they may help stabilize the acrosome membrane of
the bovine sperm, determined by decreased post-thaw acrosome
damage when FAA is added before cryopreservation. Barrios et al.
[16] demonstrated that the absorption of isolated proteins from the
seminal plasma can reduce the damage that cold shock can have
on the sperm membrane. Results of a study by Mogielnicka-
Brzozowska et al. [17] indicated that zinc-binding proteins of boar
seminal plasma have a shielding effect on the plasma membrane
and acrosome of spermatozoa, protecting these structures against
consequences of cold shock. Mogielnicka-Brzozowska and Kordan
[18] mentioned the possibility of adding specific plasma proteins to
sperm for the rentention of features responsible for the efficient
fertilization after storage.
The production of recombinant TIMP-2 and recombinant FAA
has been described previously in the scientific literature. To obtain
recombinant TIMP-2, an isolation of the total RNA was required
from the bovine seminal vesicles, after which RT-PCR was used
for the cloning, detection and the analysis of the sequence of the
product obtained [19]. As a result, a fragment of 650 base pairs of
the bovine TIMP-2 gene was obtained, which corresponds to 96%
of the complete gene and contains all of the codons of the amino
acid sequence for the desired TIMP-2 protein [19]. To obtain the
FAA, a vector of highly induced expression was cloned in E. coli, a
fragment of 592 base pairs from cDNA of FAA, corresponding to
the amino acid residues 73 to 269 of the original protein [20].
The use of recombinant proteins for fertility trials in cattle is
rare in the scientific literature. A recent in vitro fertilization (IVF)
study by Ordonez-Leon et al. (2011) [21] and an AI study by
Agado et al. (2011) [22] used recombinant FAA and TIMP-2 with
frozen-thawed sex-sorted semen, but the results did not demon-
strate a significant increase in fertility in either study. In another
study, Amann et al. (1999) [23] used a synthetic peptide from rat
prosaposin for a fertility field trial using cattle that resulted in
improved fertility.
The present study aimed to test newer methods for increasing
the fertility of cattle maintained in humid tropical conditions, more
specifically, using the addition of recombinant heparin binding
proteins (rHBPs) to conventional semen pre-cryopreservation. In
this particular study, it appears that the difficult environmental
conditions experienced by the cattle negatively impacted the
results, as both control and treatment groups demonstrated a
lower fertility than would be expected. However, the overall aim of
demonstrating the applicability of these rHBPs was achieved, as
the treatment group maintained a significantly higher fertility than
the control group.
Results
Compared to the control group, a larger proportion of
gestations occurred in the animals with the HBP treatment, and
for both body condition score (BCS) groups (Cochran-Maentel-
Haenszel test, P = 0.0009). The frequencies and percentages of
gestations observed are included in Table 1. The estimated
homogeneous odds ratio was 8.37, indicating a strong association
between the proportion of gestations and treatment with rHBPs for
both BCS groups. Evidence that the effect of the rHBPs depended
on body condition (Breslow-Day statistical test using the Tarone
adjustment, P = 0.33) was not observed. The results of these tests
indicate that a good model for explaining the proportion of the
gestations is the logistic model with the effects for the rHBPs and
the BCS [24]. A summary of the logistic regression analysis results
are presented in Table 1 and Table 2 and show the percentages of
gestations for the different experimental conditions estimated by
the respective model using a 95% confidence interval.
The percentage of controlled internal drug release (CIDR)
devices retained was 100% for both the control group and the
rHBP treatment group. Regarding the presentation of estrus, the
control group experienced a 96% estrus and the rHBP group a
92% estrus; therefore not demonstrating a statistically significant
difference between the groups (P = 0.19), presented in Table 3.
The AI was done at 24 to 26 h after the second injection of
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estradiol benzoate (EB), or 48 to 50 h after the removal of the
CIDRs in the animals that did not show signs of estrus.
Natural FAA and TIMP-2 Levels Versus rFAA and rTIMP-2
Binding
Bovine sperm samples testing negative for FAA, negative
controls, from Midland Bioproducts CorporationH verified that
the FAA conjugated antibody was not cross-reacting (Figure 1).
Similar to McCauley et al. [11], depending upon the presence of
either protein on sperm, the fluorescence binding patterns were
observed in either the acrosomal region, postacrosomal region,
acrosomal and postacrosomal regions, or no fluorescence if both
proteins were absent (Figure 2).
Discussion
The rHBP treatment group in the present research was 24%
more fertile (based on pregnancy rate) than the control group,
which is higher than that reported by Sprott et al. [7] who
obtained an increase of 16.3% in the pregnancy rate in heifers
with synchronized estrus, upon using frozen-thawed semen from
FAA positive bulls. Notably, they obtained a 62% pregnancy rate
and in the present research the results were lower, i.e., a 40%
pregnancy rate. This difference in these results could be because in
their study they used bulls that tested positive for only naturally
occurring FAA and in the present research recombinant FAA and
TIMP-2 were added, both produced via genetic engineering. In
the present study, the overall pregnancy rate in the first service was
28%. This result is similar to that reported by Bo´ et al. [25] who
reported pregnancy rates of 28.7% to 66.9% in cows and heifers
treated with CIDRs, EB and fixed time artificial insemination
(FTAI) 26–32 hours after CIDR removal.
During the course of this experiment, above normal ambient
temperatures were prevalent and at times exceeded 40uC, which
could have had an influence on the lower pregnancy percentages
obtained. Another important aspect to consider is that during the
hot period, the embryo death rate markedly increased during days
7 and 14 of gestation [26]. In terms of the molecular aspects
related to the resistance of heat stress, one can find that heat shock
proteins (HSP) have been detected not only in gametes but also in
early stage embryos. The HSP can increase or decrease the
expression of the different isoforms of the progesterone receptors,
which in turn can increase or decrease the effect of progesterone;
this aspect can influence the levels of progesterone, and therefore
can influence the gestation [27].
Since this experiment was conducted during the dry season,
there was not an abundance of forage and the available forage was
not of good nutritional quality. This aspect of available forage
affects the metabolism of the individuals and generates a negative
energy balance (NEB). It is well documented that insulin-like
growth factor 1 (IGF-1) increases the number of binding sites to
luteinizing hormone (LH) and potentially the production of LH.
The NEB causes a decrease in the circulating concentration of
IGF binding proteins (IGFBPs). This decrease in IGFBPs can
affect the luteinization of the corpus luteum (CL), which could
generate a dysfunctional CL, possibly resulting in the insufficient
production of progesterone for maintaining the gestation and
ultimately could cause the resorption of the embryo [28].
In terms of the results obtained for the AI at first service utilizing
the two types of semen, the fertility of the females inseminated with
the rHBPs (FAA and TIMP-2) added to the semen increased
compared to the control group. Given these aforementioned
results, one can conclude that the addition of the rHBPs utilized in
this study can improve fertility, consequently increasing the
pregnancy rate in heifers. In this way, the addition of these
proteins to bovine semen before cryopreservation can be a useful
tool to improve the results of reproductive programs that involve
cattle in tropical climates. With regard to the pregnancy rate in
relation to BCS, some heifers with a poor body condition
presented gestation with the rHBPs, while not a single one
succeeded in producing a gestation with the control semen. Based
on this, it is possible to conclude that the addition of rHBPs to the
semen can increase fertility in cattle when conditions may not be
favorable for reproduction under normal circumstances. Until
now, this is the first research effort that reports the successful use of
rFAA and rTIMP-2 in a synchronized AI program in cattle under
tropical conditions.
Under the previously mentioned conditions, the HBP treated
semen increased the fertility with respect to the control group.
Although we used cattle as a model in the present research, the
application could be extended for wider use in domestic animal
husbandry, assisted reproductive techniques for endangered
species, and even human clinical treatments. We recommend that
additional experiments be conducted to determine if the positive
results in the present study can be achieved under different
environmental conditions, other breeds of cattle, or even in other
species.
With advances in such fields as proteomics it is now possible to
identify proteins much more efficiently. Similarly, given the
increasing efficiency in recombinant production techniques, there
will likely become a more widespread use as the costs of
Table 1. Comparison of body condition scores (BCS) and the
number of gestational females in each experimental group
which consisted of crossbred heifers inseminated with
cryopreserved sperm with (treatment) or without (control)













4 Treatment 6 30 20 17.9 (8.3, 34.6)
Control 0 22 0 2.8 (0.7, 10)
6 Treatment 14 20 70 73.0 (51.6, 87.3)
Control 8 28 29 26.4 (13.8, 44.5)
*Estimated values with the logistic model (a 95% confidence interval).
doi:10.1371/journal.pone.0065083.t001
Table 2. Fitted model of the logistic regression analysis of the
pregnancy rates for estimating the percentages of gestations
under the different experimental conditions:
logit(P(Y~1))~azb1HBPszb2BCS.
Coefficients Estimate Std. Error z-value P(ZwDzD)
Intercept 23.54 0.69 25.14 2.7e-07
rHBPs 2.51 0.62 4.08 4.54e-05
BCS 2.02 0.60 3.40 0.0007
Null deviance: 30.63 on 3 degrees of freedom.
Residual deviance: 1.5 on 1 degree of freedom.
Akaike Information Criterion (AIC): 17.8.
rHBPs = recombinant heparin binding proteins, 0 or 1 for the treatment or
control group, respectively.
BCS = body condition score, 0 or 1 for BCS = 4 or 6, respectively.
doi:10.1371/journal.pone.0065083.t002
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production decrease. Although our study is limited in terms of
sample size, due to the expense of the recombinant proteins, this
investigation does demonstrate that the potential use for fertility
enhancement applications exists. Perhaps this work will provoke
other creative ideas or inspire others to consider alternative uses
for such biotechnologies. For example, if recombinant proteins can
act to deter neutrophils, if that is what is truly occurring based on
previous research; then perhaps similar deterrent or cloaking
mechanisms could be designed for other situations.
Table 3. Percentages of controlled internal drug release (CIDR) devices retained, presentation of estrus and gestations









Group A (Control) 50 50 (100%) 48 (96%) 8 (16%)
Group B (rHBPs) 50 50 (100%) 46 (92%) 20 (40%)
Total 100 100 (100%) 94 (94%) 28 (28%)
Group A (Control) = crossbred heifers inseminated with cryopreserved, frozen-thawed sperm without added recombinant heparin binding proteins (rHBPs), i.e., control
group. Group B (rHBPs) = crossbred heifers inseminated with cryopreserved, frozen-thawed sperm with added rHBPs, i.e., treatment group.
doi:10.1371/journal.pone.0065083.t003
Figure 1. Visualization of representative control and treatment sperm samples included the following: a) fertility associated
antigen (FAA) antibody control sample (FAA negative) without FAA present on sperm (provided by Midland Bioproducts
CorporationH) and verified after the application of fluorescein conjugated FAA antibody, b) FAA protein control sample (FAA
negative, provided by Midland Bioproducts CorporationH) with fluorescein conjugated FAA recombinant protein added to sperm,
c) fluorescein conjugated Type-2 tissue inhibitor of metalloproteinase (TIMP-2) antibody added to sperm, and d) fluorescein
conjugated TIMP-2 protein added to sperm.
doi:10.1371/journal.pone.0065083.g001
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Materials and Methods
Ethics Statement
All of the animals used in this research were treated in
accordance to the Federation of Animal Science Societies (FASS)
guide for use of farm animals in research and teaching [29]. The
present study took place between May 16 and July 3, 2010 in the
state of Tabasco, Mexico, situated in the humid tropical region of
Mexico, Latitude North 17u599 and Latitude West 92u569 at an
elevation of 10 m above sea level. The climate is typically hot and
humid with abundant rainfall in the summer with an average
temperature in this region of ,33.6uC and annual cumulative
rainfall of 2,237 mm [30].
Semen Collection and Semen Characteristics
Semen was collected from one Brahman bull by means of an
artificial vagina. The ejaculates were only used for processing
conventional straws of semen if they met the following criteria:
minimum motility of $55%, primary abnormal morphologies
#15%, secondary abnormal morphologies #15%, and a total
abnormal morphology count not to exceed 25%. Further, samples
used in the post-thaw analyses had to meet standard quality
control conditions of motility $45% at 0 h and $30% at 3 h
when incubated at 37uC. The post-thaw intact acrosomes were
$50% at 3 h.
For all semen quality evaluations, 25.4 6 76.2 mm glass
microscope slides (Andwin, Addison, IL) and 226 22 mm #1.5
coverslips (Thomas Scientific, Swedesboro, NJ, USA) were used.
All motility assessments were made using brightfield microscopy
and post-thaw intact acrosomes and morphology assessments
utilized differential interference contrast (DIC) microscopy at
400X. Samples were viewed using a Nikon Eclipse 80i microscope
(Nikon Instruments Inc., Melville, NY, USA).
Figure 2. Sperm from the Brahman bull used in this study with: a) fluorescein conjugated Type-2 tissue inhibitor of
metalloproteinase (TIMP-2) antibody revealing natural levels and location of TIMP-2 protein, b) fluorescein conjugated TIMP-2
recombinant protein adsorption by sperm, c) fluorescein conjugated fertility associated antigen (FAA) antibody revealing natural
levels and location of FAA protein, and d) fluorescein conjugated FAA recombinant protein adsorption by sperm.
doi:10.1371/journal.pone.0065083.g002
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Obtaining Recombinant FAA and Recombinant TIMP-2
The present study formed part of a larger collaborative project
between Texas A&M University, Sexing Technologies, and the
Facultad de Estudios Superiores Cuautitlan, UNAM. The semen,
both with and without the HBPs, was prepared and cryopreserved
by Sexing Technologies. The recombinant FAA and TIMP-2
proteins used in the present study were provided by TMI
Laboratories International, Inc. and added at Sexing Technolo-
gies.
Identification of Natural Levels of FAA and TIMP-2:
Indirect Immunofluorescence
TIMP-2 antibody (ab38975) (Abcam Inc., Cambridge, MA,
USA) and FAA antibody (Midland Bioproducts CorporationH)
were purchased and directly conjugated using Lightning-LinkTM
Fluorescein conjugation kit (Innova Biosciences: Product # 707 -
0010, 0015, Batch # 606, 678, and 686). VECTASHIELDH
Mounting Medium for Fluorescence (Cat. No. H-1000, Lot#
U1017, Vector Laboratories Inc., Burlingame, CA, USA) was used
to reduce photobleaching. Samples were viewed using a Nikon
Eclipse 80i microscope with fluorescence capabilities and NIS
Elements BR 3.00 imaging software [31] with a CCD camera,
specifically a PhotometricsH CoolSNAPTM 164 EZ (Photometrics,
Tucson, AZ, USA), for photographing.
To verify that the FAA conjugated antibody was not cross-
reacting, negative controls were used. Bovine sperm samples that
tested negative for FAA, i.e., sperm not having FAA protein, were
obtained from Midland Bioproducts CorporationH.
Addition and Verification of FAA and TIMP-2 Binding
For this research, 25 mg of FAA and 25 mg of TIMP-2 were
added per milliliter of semen, and then left to adsorb for 20 min at
,21uC, after which the semen was diluted and cooled to about
5uC prior to packaging and cryopreservation. Adsorption of the
recombinant proteins was verified both by directly conjugating the
recombinant proteins using the Lightning-LinkTM Fluorescein
conjugation kit (Innova Biosciences: Product # 707 - 0010, 0015,
Batch # 606, 678, and 686), as well as using the conjugated
antibody procedure similar to that used in identifying the natural
levels of FAA and TIMP-2. Samples were viewed both before and
after treatment with recombinant proteins using a Nikon Eclipse
80i microscope with fluorescence capabilities and NIS Elements
BR 3.00 imaging software [31] with a CCD camera, specifically a
PhotometricsH CoolSNAPTM 164 EZ (Photometrics, Tucson, AZ,
USA), for photographing.
Semen Extender Preparation
All of the chemicals used in making the semen extenders were
purchased from Amresco (AMRESCOH Inc., Solon, OH, USA).
The semen extenders used in the experiments were prepared using
the standard protocols and procedures within Sexing Technologies
and consisted of the same formulation having a pH of 6.8 and an
osmolality balanced at ,30065 mOsm/Kg for the Tris A
extender. For testing on a batch-to-batch basis, Tris B extender
was diluted 3:1 (A:B) and vortexed with a final osmolality of
830 mOsm/Kg [32]. The formula of the Tris A semen extender
utilized consisted of the following: 7.57 g TRIS, 4.32 g Citric Acid
Monohydrate (CAM), 2.25 g Fructose, 50 mL (20% v/v) egg yolk,
50 mg/mL Tylosin, 250 mg/mL Gentamycin, 150/300 mg/mL
Lincomycin-Spectinomycin, and Nanopure Water 18.2 MilliQ
added to make a total of 250 mL extender. The antibiotic
guidelines are approved by Certified Semen Services of the
National Association of Animal Breeders (NAAB). The Tris B
extender differs from the Tris A extender in that it contains
glycerol, i.e., 14% (v/v). The Tris A extended fraction containing
the semen sample is allowed to cool to about 5uC, after which the
Tris B extender of similar temperature is added incrementally, in
order to reduce osmotic shock. The final mix of the two extenders
used to dilute the bull semen pre-cryopreservation was a 1:1 ratio
of A and B fractions of respective extenders, with a final glycerol
content of 7%. Semen was placed in 0.5 mL french straws at a
concentration of 25 6 106 sperm per straw (IMV Technologies,
L’Aigle, France) and cryopreserved using an automated freezing
device, IMV DigitcoolH (IMV, Cedex, France) and stored in liquid
nitrogen.
AI of Heifers
For this experiment, a total of 100 tropically-adapted cross-bred
commercial heifers (Bos indicus6Bos taurus genotype) were selected.
From these animals, two groups were formed by random selection;
the heifers in the control group (n = 50) were inseminated with
semen not having rHBPs added and the treatment group heifers
(n = 50) were inseminated with semen having the added rHBPs
(rFAA and rTIMP-2).
Inclusion Criteria
The heifers were selected for this experiment by taking into
account their cyclicity, BCS, weight, anatomic conformation and
genital anatomy.
Cyclicity. The ovarian activity was evaluated by means of
real-time ultrasound (mode-B) with a 7.5 MHz linear array
transducer (VetPreg, China) and the selected animals had at least
a follicle size of $8 mm and a CL.
Body condition and anatomic conformation. Animals
were selected with a BCS of 4 (average of 320 kg) to 6 (average
of 350 kg) on a scale of 1 to 9 where 1 is very thin and 9 is
considered obese [33]. The anatomical conformation was evalu-
ated by means of pelvimetry [34].
Genital anatomy. Animals were selected with normal genital
anatomy with reference to the presence of ovaries, uterine horns,
cervix and vulva, by means of transrectal palpation.
Exclusion criteria. Females with anatomic abnormalities,
anestrus and/or with BCS of 3 or less were not selected for the
experiment.
Estrus Synchronization and Ovulation
The heifers were synchronized for presenting estrus in the
following manner: Day 0, they received an intramuscular (IM)
injection of 2 mg of EB, 500 mg of CelosilH prostaglandin F2a
(PGF2a; Schering-Plough, Me´xico) and a CIDR was inserted
containing 1.38 g of progesterone; Day 7, the CIDR was removed
and heifers were administered 500 mg of CelosilH (PGF2a) by IM
injection; Day 8, heifers were IM injected with 0.5 mg EB [25],
[35].
Estrus Detection
Direct observation was the method used for detecting estrus in
the heifers, and once identified the base of the tail was painted with
a colored marker. The marking was done on Day 8 of
synchronization at the time of injecting the second dose of EB.
The observation for detection of estrus began at 6:00 to 7:00 pm
on Day 8 of synchronization and at 5:00 am on Day 9 of
synchronization. Those heifers that lost their colored marker were
inseminated first [36], given that in a tropical climate the
presentation of estrus typically occurs between 6:00 pm and 6:00
am [37]. The animals that were not identified as being in estrus
Gamete Therapeutics: Recombinant Protein Adsorption
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were inseminated at a fixed time of 52 to 56 h after the removal of
the CIDR.
Artificial Insemination
The heifers were inseminated using the rectovaginal technique
and forming 2 groups at random of 50 animals each. The control
group was inseminated with cryopreserved bovine semen without
HBPs and the HBP treatment group was inseminated with
cryopreserved bovine semen containing 25 mg/mL of FAA and
25 mg/mL TIMP-2. The inseminations were performed 24 to
26 h after the second injection of EB and removal of the CIDR.
Pregnancy Diagnosis
Pregnancy was diagnosed by means of real-time ultrasound
(mode-B) with a linear array transducer of 7.5 MHz (VetPreg,
China), at 45 days post insemination.
Statistical Analysis
In both groups, treatment and control, the percentage of
gestation at first service was determined, as well as gestation
correlating to body condition. The Breslow-Day statistical test
using the Tarone adjustment [38] was utilized to test the
interaction effects of the BCS and the rHBPs on the gestation
rate. The independence of the gestation rate and the treatment
with rHBPs factoring for the BCS was tested using the Cochran-
Mantel-Haenszel test. A logistic model was also created with the
effects of the rHBPs and the BCS for estimating the percentages of
gestation and associated standard error. The statistical analysis was
made with the software R [39]; specifically for the Breslow-Day
test the metafor package of R [40] was utilized. A comparison was
made of the proportions of the animals that entered estrus in each
group by means of a Z test.
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